Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dornase alfa, ATC R05CB13 für die Zeit 01.07.2026 - 30.06.2028
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Etravirin, ATC J05AG04 für die Zeit 01.07.2026 - 30.06.2028
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Erythropoetin (ausschließlich Epoetin alfa und zeta), ATC B03XA01 für die Zeit 01.07.2026 - 30.06.2028
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Piribedil, ATC N04BC08 für die Zeit 01.07.2026 - 30.06.2028
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Propranolol (ausschließlich Darreichungsform LSE), ATC C07AA05 für die Zeit 01.07.2026 - 30.06.2028
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ixekizumab, ATC L04AC13 für die Zeit 01.07.2026 - 30.06.2028
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Carglumsäure, ATC A16AA05 für die Zeit 01.07.2025 - 30.06.2027 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Cyanocobalamin, ATC B03BA01 für die Zeit 01.07.2025 - 30.06.2027 (zzgl. Verlängerungsoption 1x 12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Lenalidomid, ATC L04AX04 für die Zeit 01.07.2025 - 30.06.2027 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Epinephrin, ATC C01CA24 für die Zeit 01.07.2025 - 30.06.2027 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Lapatinib, ATC L01EH01 für die Zeit 01.07.2025 - 30.06.2027 (zzgl. Verlängerungsoption 1x 12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Fusidinsäure, ATC D06AX01 für die Zeit 01.07.2025 - 30.06.2027 (zzgl. Verlängerungsoption 1x12 Monate)
France – Hotel services – Système d'achat de nuitées hôtelières pour l'hébergement d'urgence des personnes en situation d'exclusion en Ile-de-France
ted.europa.eu
Buyer: GROUPEMEMENT D'INTERET PUBLIC SAMUSOCIAL DE PARIS | Notice type: cn-social | Procedure: oth-mult | Contract: services | Deadline: 2028-05-05
TenderProcurement ContractFranceOpen
AmountNot provided on the source page. Please check the official source.
DeadlineMay 5, 2028
Buyer: GROUPEMEMENT D'INTERET PUBLIC SAMUSOCIAL DE PARIS | Notice type: cn-social | Procedure: oth-mult | Contract: services | Deadline: 2028-05-05
TEN
France – Hotel services – Système d'achat de nuitées hôtelières pour l'hébergement d'urgence des personnes en situation d'exclusion en Ile-de-France
ted.europa.eu
Buyer: GROUPEMEMENT D'INTERET PUBLIC SAMUSOCIAL DE PARIS | Notice type: cn-social | Procedure: oth-mult | Contract: services | Deadline: 2028-05-05
TenderProcurement ContractFranceOpen
AmountNot provided on the source page. Please check the official source.
DeadlineMay 5, 2028
Buyer: GROUPEMEMENT D'INTERET PUBLIC SAMUSOCIAL DE PARIS | Notice type: cn-social | Procedure: oth-mult | Contract: services | Deadline: 2028-05-05
GRA
Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
grants.gov
This Notice of Funding Opportunity (NOFO) invites applications that propose to use mouse models to conduct rigorous preclinical testing of drugs or dr...
GrantCash GrantUnited StatesOpen
AmountAward ceiling: $1,000,000
DeadlineMay 7, 2028
This Notice of Funding Opportunity (NOFO) invites applications that propose to use mouse models to conduct rigorous preclinical testing of drugs or drug combinations currently used for other conditions, as well as investigational drugs at various stages of clinical development, predicted to be efficacious in AD/ADRD. This initiative will also support preclinical testing of repurposable or investigational drug candidates in combination with non-pharmacologic interventions leading to robust translational outcomes. The central goal is to establish robust proof of concept that will enable rational drug repurposing and combination therapy development for the treatment and prevention of AD/ADRD.
GRA
Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)
grants.gov
The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Traini...
GrantCash GrantUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineMay 7, 2028
The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grants (T35) to eligible, domestic institutions to develop and/or enhance research training opportunities for predoctoral students interested in careers within biomedical, behavioral, or clinical research workforce. Many NIH Institutes and Centers (ICs) use this NRSA program exclusively to support intensive, short-term research training experiences for health professional students (medical students, veterinary students, and/or students in other health-professional programs) during the summer. This program is also intended to encourage training of graduate students in the physical or quantitative sciences to pursue interests in research careers by short-term exposure to, and involvement in, the health-related sciences. The training should be of sufficient depth to enable the trainees, upon completion of the program, to have a thorough e...
GRA
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33)
grants.gov
The National Institutes of Health (NIH) awards senior individual research training fellowships to experienced scientists who wish to make major change...
GrantCash GrantUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineMay 7, 2028
The National Institutes of Health (NIH) awards senior individual research training fellowships to experienced scientists who wish to make major changes in the direction of their research careers or who wish to broaden their scientific background by acquiring new research capabilities as independent investigators in research fields relevant to the missions of participating NIH Institutes and Centers.
GRA
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)
grants.gov
The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral (Parent F31) award is to enable promising predoct...
GrantCash GrantUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineMay 7, 2028
The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral (Parent F31) award is to enable promising predoctoral students will obtain individualized, mentored research training from outstanding faculty sponsors while conducting dissertation research projects in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The proposed mentored research training must reflect the candidates dissertation research project and is expected to clearly enhance the individuals potential to develop into a productive, independent research scientist. This Notice of Funding Opportunity (NOFO) does not allow candidates to propose to lead an independent clinical trial but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.
No saved opportunities on this page
Use the star icon near an opportunity title to add it to Favorites.
📅 Best viewed on desktop - or rotate your phone to landscape mode.
France – Hotel services – Système d'achat de nuitées hôtelières pour l'hébergement d'urgence des personnes en situation d'exclusion en Ile-de-FranceBuyer: GROUPEMEMENT D'INTERET PUBLIC SAMUSOCIAL DE PARIS | Notice type: cn-social | Procedure: oth-mult | Contract: services | Dea...
Tender
Procurement Contract
France
Not provided on the source page. Please check the official source.
Buyer: GROUPEMEMENT D'INTERET PUBLIC SAMUSOCIAL DE PARIS | Notice type: cn-social | Procedure: oth-mult | Contract: services | Deadline: 2028-05-05
39046
France – Hotel services – Système d'achat de nuitées hôtelières pour l'hébergement d'urgence des personnes en situation d'exclusion en Ile-de-FranceBuyer: GROUPEMEMENT D'INTERET PUBLIC SAMUSOCIAL DE PARIS | Notice type: cn-social | Procedure: oth-mult | Contract: services | Dea...
Tender
Procurement Contract
France
Not provided on the source page. Please check the official source.
Buyer: GROUPEMEMENT D'INTERET PUBLIC SAMUSOCIAL DE PARIS | Notice type: cn-social | Procedure: oth-mult | Contract: services | Deadline: 2028-05-05
39047
Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)This Notice of Funding Opportunity (NOFO) invites applications that propose to use mouse models to conduct rigorous preclinical te...
This Notice of Funding Opportunity (NOFO) invites applications that propose to use mouse models to conduct rigorous preclinical testing of drugs or drug combinations currently used for other conditions, as well as investigational drugs at various stages of clinical development, predicted to be efficacious in AD/ADRD. This initiative will also support preclinical testing of repurposable or investigational drug candidates in combination with non-pharmacologic interventions leading to robust translational outcomes. The central goal is to establish robust proof of concept that will enable rational drug repurposing and combination therapy development for the treatment and prevention of AD/ADRD.
39048
Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Instituti...
Grant
Cash Grant
United States
Not provided on the source page. Please check the official source.
The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grants (T35) to eligible, domestic institutions to develop and/or enhance research training opportunities for predoctoral students interested in careers within biomedical, behavioral, or clinical research workforce. Many NIH Institutes and Centers (ICs) use this NRSA program exclusively to support intensive, short-term research training experiences for health professional students (medical students, veterinary students, and/or students in other health-professional programs) during the summer. This program is also intended to encourage training of graduate students in the physical or quantitative sciences to pursue interests in research careers by short-term exposure to, and involvement in, the health-related sciences. The training should be of sufficient depth to enable the trainees, upon completion of the program, to have a thorough exposure to the principles underlying the conduct of biomedical research.
39049
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33)The National Institutes of Health (NIH) awards senior individual research training fellowships to experienced scientists who wish...
Grant
Cash Grant
United States
Not provided on the source page. Please check the official source.
The National Institutes of Health (NIH) awards senior individual research training fellowships to experienced scientists who wish to make major changes in the direction of their research careers or who wish to broaden their scientific background by acquiring new research capabilities as independent investigators in research fields relevant to the missions of participating NIH Institutes and Centers.
39050
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral (Parent F31) award is to enab...
Grant
Cash Grant
United States
Not provided on the source page. Please check the official source.
The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral (Parent F31) award is to enable promising predoctoral students will obtain individualized, mentored research training from outstanding faculty sponsors while conducting dissertation research projects in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The proposed mentored research training must reflect the candidates dissertation research project and is expected to clearly enhance the individuals potential to develop into a productive, independent research scientist. This Notice of Funding Opportunity (NOFO) does not allow candidates to propose to lead an independent clinical trial but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.
No saved opportunities on this page. Use the star icon near an opportunity title.
